Acne Medicine Market Revenue 2024 to 2034
Acne Medicine Market Revenue 2024 to 2034
The global acne medicine market was estimated at US$ 13.44 billion in 2023 and is projected to grow to US$ 23.33 billion by 2034, rising at a compound annual growth rate (CAGR) of 5.14% from 2024 to 2034. The rising prevalence of skin-related conditions due to a poor diet, a lack of exercise, an unhealthy lifestyle, health abnormalities, or hormonal imbalance issues are leading to the surge of innovations in effective medical treatments contributing to the growing success of the acne medicine market.
Report ID: 10275
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 14.13 Bn
Forecast Year,
USD USD 23.33 Bn
CAGR, 2025 -
5.14%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Acne Medicine Market Size Analysis
Acne Medicine Market Size By Therapeutic Class 2024 to 2034 (USD )
| Therapeutic Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical and Combination Retinoid | 9.86 | 10.34 | 10.84 | 11.36 | 11.91 | 12.49 | 13.09 | 13.73 | 14.39 | 15.09 | 15.81 |
| Oral Retinoid | 4.27 | 4.52 | 4.78 | 5.06 | 5.35 | 5.66 | 5.99 | 6.34 | 6.71 | 7.10 | 7.51 |
Acne Medicine Market Size By Formulation 2024 to 2034 (USD )
| Formulation | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical Medication | 6.33 | 6.63 | 6.94 | 7.26 | 7.60 | 7.95 | 8.32 | 8.71 | 9.12 | 9.54 | 9.98 |
| Oral Medication | 4.97 | 5.26 | 5.56 | 5.88 | 6.22 | 6.57 | 6.95 | 7.35 | 7.76 | 8.21 | 8.68 |
| Antibiotics | 2.83 | 2.97 | 3.12 | 3.28 | 3.45 | 3.63 | 3.82 | 4.01 | 4.22 | 4.44 | 4.67 |
Acne Medicine Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prescription Medicines | 5.62 | 5.88 | 6.15 | 6.44 | 6.73 | 7.04 | 7.37 | 7.71 | 8.06 | 8.43 | 8.82 |
| Oral Antibiotics | 3.52 | 3.68 | 3.86 | 4.04 | 4.23 | 4.43 | 4.64 | 4.86 | 5.09 | 5.32 | 5.57 |
| Hormonal Treatments | 2.85 | 3.03 | 3.22 | 3.42 | 3.63 | 3.85 | 4.08 | 4.33 | 4.60 | 4.88 | 5.18 |
| Oral Contraceptive Tablets | 2.13 | 2.26 | 2.39 | 2.53 | 2.68 | 2.83 | 3.00 | 3.17 | 3.35 | 3.55 | 3.76 |
Acne Medicine Market Size By Acne Type 2024 to 2034 (USD )
| Acne Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-inflammatory Acne | 7.74 | 8.11 | 8.50 | 8.90 | 9.32 | 9.77 | 10.23 | 10.72 | 11.23 | 11.76 | 12.32 |
| Inflammatory Acne | 6.39 | 6.74 | 7.12 | 7.52 | 7.94 | 8.39 | 8.86 | 9.35 | 9.87 | 10.43 | 11.01 |
Acne Medicine Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail Store | 5.62 | 5.88 | 6.15 | 6.44 | 6.73 | 7.04 | 7.37 | 7.71 | 8.06 | 8.43 | 8.82 |
| Pharmacy and Drug Store | 8.51 | 8.97 | 9.47 | 9.99 | 10.53 | 11.11 | 11.72 | 12.36 | 13.04 | 13.75 | 14.51 |
Acne Medicine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4.90 | 5.11 | 5.33 | 5.55 | 5.78 | 6.03 | 6.28 | 6.54 | 6.82 | 7.10 | 7.39 |
| Asia Pacific | 3.59 | 3.83 | 4.09 | 4.37 | 4.66 | 4.97 | 5.31 | 5.66 | 6.03 | 6.43 | 6.86 |
| Europe | 2.81 | 2.94 | 3.08 | 3.22 | 3.37 | 3.52 | 3.68 | 3.85 | 4.03 | 4.22 | 4.41 |
| Latin America | 1.41 | 1.49 | 1.56 | 1.64 | 1.73 | 1.82 | 1.91 | 2.01 | 2.11 | 2.22 | 2.33 |
| Middle East and Africa | 1.41 | 1.49 | 1.56 | 1.64 | 1.73 | 1.82 | 1.91 | 2.01 | 2.11 | 2.22 | 2.33 |
Acne Medicine Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
